Other

Sinphar Pharmaceutical Co., Ltd.

Nuliv Holding Inc.

National Defense Medical Center

Sinphar Tian-li Pharmaceutical Co., Ltd. (hangzhou)

Buddhist Tzu Chi General Hospital

Giant Force Technology Corporation

Wen-Liang Chang

Hang-Ching Lin

Chen-Wen Yao

Tsu-Chung Chang

Hui Ling Tseng

Wan Ping Tseng

Tai Lin Tseng

Yin Yu Kuo

Hsiou-Yu Ding

I-Chuan Yen

Ann Chen

An-Rong Lee

Wen-Hsin Huang

Kuo-Yuan Hwa

Hsin-Wen Huang

Yuan Yang

Chien-Lian Chao

Chi-Hong Chu

Shinn-Zong Lin

Horng-Jyh Harn

Shuk-Man Ka

Kuo-Feng Hua

Chin-Liang Lin

Li-Heng Pao

Kuo-Ping Chao

Shu-Fen Huang

Tian Shung Wu

Jiann-Kuan Luo

Yeung-Leung Cheng

Nu-Man Tsai

Yu-Chuan Huang

Hang-Chin Lin

Jerming Tseng

Chiao-Ying Chien

Yi-Yang Song

Chien-Yi Pai

Hsiou Yu Ding

The present invention relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against influenza virus. The present invention also relates to a use of mycophenolate mofetil or a pharmaceutically acceptable salt thereof in the manufacture of a medicament against drug-resistant influenza virus strains. The present invention is further related to a method for treating influenza in a subject, comprising administering to said subject an effective amount of mycophenolate mofetil or a pharmaceutically acceptable salt thereof.

Usage of mycophenolate mofetil or salt thereof in preparing drug for resisting against influenza virus

The present invention discloses a novel use of a lanostane having the following formula (I) in enhancing uptake of nutrients: wherein Ris either H or CH; Ris OCOCH, &#x2550;O or OH; Ris H or OH; Ris &#x2014;C(&#x2550;CH)&#x2014;C(CH)R, in which Ris H or OH, or &#x2014;CH&#x2550;C(CH)&#x2014;R, in which Ris CHor CHOH; Ris H or OH; and Ris CHor CHOH.

[object Object]

Disclosed is a method for inhibiting cancer cell growth in a subject in need thereof, comprising administering to the subject an effective amount of a compound from, wherein the compound is represented by formula (I): wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.

Method for inhibiting cancer cell growth

Disclosed is a compound isolated from, represented by formula I: wherein R1 is a hydrogen atom or an acetyl group; and a method of inhibiting cancer cell growth by using the compound, the cancer is selected from the group consisting of lung cancer, colon cancer, prostate cancer, liver cancer and breast cancer.

Compound, extract isolated from antrodia camphorate, and method using the same

The present invention provides a use of compounds fromin manufacturing medicaments for treating kidney diseases, wherein the compounds is represented by formula (I): wherein Ris a hydrogen atom or acetyl group, Ris wherein the kidney disease is glomerulosclerosis or glomerulonephritis.

A pharmaceutical composition for treating diabetes is provided in this invention. The composition contains a lanostane compound as a potent component. A suitable source of the lanostane compound is aextract from metabolite, sclerotium, or fermentation product of(Schw) Wolf. Theextract contains 1-60% of the lanostane compounds by weight of the extract, and is devoid of secolanostane.

A pharmaceutical composition is used to enhance immunity of the human body. The composition contains potent components of lanostane compounds. A method is devised to obtain an extract from metabolite, sclerotium, or fermentation product of(Schw) Wolf. The extract contains 5-60% of the lanostane compounds by weight of the extract. The extract is devoid of secolanostane capable of inhibiting immunity development.

The present invention relates to a new use of citral for manufacturing a medicament for treating focal segmental glomerulosclerosis (FSGS). Particularly, the present invention discloses that citral is effective in alleviating symptoms of FSGS, including reducing glomerular epithelial hyperplasia lesions (EPHLs), peri-glomerular inflammation or glomerular hyalinosis or sclerosis, and also reducing proteinuria or hematuria or lowering serum urea nitrogen level or serum creatinine level in the subject.

Use of citral for treating focal segmental glomerulosclerosis

Disclosed are an Schisandrae fructus extract for inhibition or prevention of influenza and its application, wherein the Schisandrae fructus extract is obtained by water, methanol, or ethanol extraction process and the extract comprises compounds such as schisandrone, benzoylgomisin P, wulignan A1, epigomisin O, epiwulignan A1, and tigloylgomisin P. The extracts and purified compounds of Schisandrae fructus has anti-influenza virus H1N1 and H1N1-TR (a Tamiflu drug resistant virus strain) activities, therefore the extracts and the purified compounds of Schisandrae fructus can be applied as an inhitibory agent of a pharmaceutical composition for treatment or prevention agent for influenza infection.

The present application relates to a method for enhancing absorption of a nutrient in a subject in need thereof with an effective amount of an isolated astragaloside compound.

Method for enhancing nutrient absorption with astragalosides

A method of treating a disease associated with cartilage defect in a subject in need thereof by administering to the subject an effectively amount of a cycloartane compound of Formula (I).

Use of cycloartane compounds for treating arthritis

A method for skin care includes administering the water insoluble fraction of, or astragaloside compounds thereof to a subject in need thereof at an effective amount for improving skin texture, reducing wrinkles, UV protection, and/or providing an anti-aging effect.

Method for skin care

The present invention discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering osteoporosis. An embodiment of this novel use is a pharmaceutical composition containing bakuchiol or an extract containing bakuchiol, which can be in the dosage forms of topical use, oral administration, injection or sustained release. The present invention also discloses a novel use of bakuchiol or an extract containing bakuchiol in preventing or treating a woman suffering breast cancer.

Pharmaceutical composition containing bakuchiol for treating woman osteoporosis

The invention provides an acetone extract, chloroform extract or hexane extract ofand/or the active components purified therefrom, such as n-butylidenephthalide, which are effective in treating cancers.

Growing community of inventors

Taipei, Taiwan

Wen-Liang Chang